Search results for "HERA"

showing 10 items of 14928 documents

The 9th International Conference of Students of Systematic Musicology (SysMus16), Jyväskylän yliopisto, June 8-10 2016 : programme, abstracts & proce…

2016

musiikkiteknologiaMusic information retreavalMusicologymusiikkimusiikkiterapiasystematic musicologymusiikintutkimusopiskelumotion capturetutkimusMusic therapytiedonhakuMusic technologyMusic
researchProduct

The sense of self of experienced and non-experienced music therapists in musical improvisation : an interpretative phenomenological analysis

2014

Music therapists’ work is constantly researched and measured in order to find the best possible ways for conducting music therapy and treating people through music. In spite of this, music therapists themselves are rarely investigated. This research had as its aim to investigate music therapists. The actual investigation involved the sense of self of a music therapist in musical improvisation through semi-structured interviews analysed with Interpretative Phenomenological Analysis. Findings of the research included accepting awareness, using the self as a tool and mutual and authentic interaction between equals. These findings coincide with previous researches supporting that music can be a…

musiikkiterapeutitMusical improvisationitsetuntemusmusiikkimusiikkiterapiaMusic TherapistimprovisointiMusic TherapySense of SelfInterpretative Phenomenological Analysis
researchProduct

Adapting to Change : How the COVID-19 Pandemic has Impacted the Music Therapy Profession

2021

COVID-19 was declared a global pandemic on March 11, 2020. Since then, it has had an undeniable impact on many aspects of society, with far-reaching effects. The COVID-19 pandemic has likely affected music therapists in various ways, as they typically work in-person with their clients, often in healthcare related settings. This study aims to investigate the COVID-19 pandemic’s impact on the professional practice of music therapists. A questionnaire was shared online to certified music therapists around the world during the early stages of the COVID-19 pandemic. There were three broad areas of inquiry that the questionnaire covered, including the situational changes and/or practical adaptati…

musiikkiterapeutitammatinharjoittajatcovid-19telehealthmusic therapymusiikkiterapiateleterveydenhuoltoprofessional practiceverkkopalvelut
researchProduct

Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.

2009

We report seven patients with immune-mediated rippling muscle disease (iRMD) and AChR-antibody positive myasthenia gravis (MG) without germline caveolin-3 gene mutations. We describe the follow-up of two patients and the clinical features of five new patients (1 female, 4 male, aged 32 to 69 years). These presented with significant generalized, exercise-induced and electrically-silent muscle rippling with myalgia, combined with generalized MG. In two of the seven patients, MG appeared before iRMD. Mediastinal imaging excluded thymic alterations in all, although two had other coincident tumours. Myalgia and rippling were aggravated by acetylcholinesterase-inhibitor treatment. Generalized MG …

myalgiaAdultMalePathologymedicine.medical_specialtyCaveolin 3Immunogenicmedicine.medical_treatmentMuscle Fibers SkeletalMuscle ProteinsCaveolin-3; Immunogenic; Myasthenia gravis; Rippling muscle disease; TherapyAzathioprineThymus GlandGene mutationBiologyCaveolaeDysferlinCaveolin-3Muscular DiseasesAzathioprineMyasthenia GravismedicineHumansMuscle SkeletalGenetics (clinical)AgedAutoantibodiesSarcolemmaElectromyographyAutoantibodyRippling muscle diseasePlasmapheresisMiddle Agedmedicine.diseaseMyasthenia gravisNeurologyPediatrics Perinatology and Child Healthbiology.proteinPlasmapheresisFemaleSteroidsTherapyNeurology (clinical)Cholinesterase Inhibitorsmedicine.symptommedicine.drugFollow-Up StudiesMuscle ContractionNeuromuscular disorders : NMD
researchProduct

MDS-191: Long-Term Efficacy and Safety of Luspatercept in Lower-Risk Myelodysplastic Syndromes (MDS): Phase 2 PACE-MDS Study

2020

Background: Luspatercept, a first-in-class erythroid maturation agent, has been investigated in patients with LR-MDS and ring sideroblasts (RS) (MEDALIST; Fenaux and Platzbecker NEJM 2020) and in an ongoing Phase 3 trial regardless of RS status (COMMANDS, NCT03682536 ). The previously reported Phase 2 trial of luspatercept (Platzbecker Lanc Onc 2017) includes subtypes of LR-MDS with and without RS, regardless of prior ESA exposure, and various EPO levels. Aims: Evaluate the long-term safety and efficacy of luspatercept in LR-MDS. Methods: Patients were IPSS low/int-1, age ≥ 18 years, Hgb NCT01749514 ; NCT02268383 ). Results: As of 13July2019, 115 patients were enrolled, of whom 108 were tre…

myalgiaCancer Researchmedicine.medical_specialtyErythemabusiness.industryMyelodysplastic syndromesPeripheral edemaPhases of clinical researchHematologymedicine.diseaseLower riskClinical trialOncologyhemic and lymphatic diseasesInternal medicinemedicinemedicine.symptomBone painbusinessClinical Lymphoma Myeloma and Leukemia
researchProduct

Effects of Coenzyme Q10 on Statin-Induced Myopathy

2015

Abstract Objective To evaluate the efficacy of coenzyme Q10 (CoQ10) supplementation on statin-induced myopathy. Participants and Methods We searched the MEDLINE, Cochrane Library, Scopus, and EMBASE databases (November 1, 1987, to May 1, 2014) to identify randomized controlled trials investigating the impact of CoQ10 on muscle pain and plasma creatine kinase (CK) activity as 2 measures of statin-induced myalgia. Two independent reviewers extracted data on study characteristics, methods, and outcomes. Results We included 6 studies with 302 patients receiving statin therapy: 5 studies with 226 participants evaluated the effect of CoQ10 supplementation on plasma CK activity, and 5 studies (4 u…

myalgiaCoenzyme Q10medicine.medical_specialtybiologybusiness.industryGeneral MedicineCochrane Librarylaw.inventionchemistry.chemical_compoundRandomized controlled trialchemistrylawStrictly standardized mean differenceInternal medicineMeta-analysisbiology.proteinPhysical therapyMedicineCreatine kinasemedicine.symptombusinessMyopathyMayo Clinic Proceedings
researchProduct

The pain threshold of high-threshold mechanosensitive receptors subsequent to maximal eccentric exercise is a potential marker in the prediction of D…

2017

Background Delayed-onset muscle soreness (DOMS) refers to dull pain and discomfort in people after participating in exercise, sport or recreational physical activities. The aim of this study was to detect underlying mechanical thresholds in an experimental model of DOMS. Methods Randomised study to detect mechanical pain thresholds in a randomised order following experimentally induced DOMS of the non-dominant arm in healthy participants. Main outcome was the detection of the pressure pain threshold (PPT), secondary thresholds included mechanical detection (MDT) and pain thresholds (MPT), pain intensity, pain perceptions and the maximum isometric voluntary force (MIVF). Results Twenty volun…

myalgiaMaleSensory ReceptorsPhysiologySensory Physiologylcsh:MedicineSocial SciencesIsometric exercisePathology and Laboratory Medicine0302 clinical medicineNerve FibersAnimal CellsMedicine and Health SciencesElbowMorphogenesisMedicinePsychologyYoung adultlcsh:ScienceImmune ResponseMusculoskeletal SystemPain MeasurementNeuronsMultidisciplinaryNociceptorsMuscle DifferentiationSensory SystemsArmsSomatosensory SystemAnesthesiaNociceptorMechanosensitive channelsFemaleSensory Perceptionmedicine.symptomCellular TypesAnatomyMechanoreceptorsMuscle contractionMuscle ContractionResearch ArticleSignal TransductionAdultPain Thresholdmedicine.medical_specialtyImmunologyPain03 medical and health sciencesYoung AdultSigns and SymptomsDiagnostic MedicineThreshold of painPressureHumansddc:610Exercise physiologyMuscle SkeletalExerciseInflammationbusiness.industrylcsh:RLimbs (Anatomy)Biology and Life SciencesPain Sensation030229 sport sciencesMyalgiaCell BiologyCellular NeurosciencePhysical therapylcsh:Qbusiness030217 neurology & neurosurgeryNeuroscienceDevelopmental BiologyPloS one
researchProduct

2015

Aim Our study aimed to investigate changes of different markers for routine assessment of fatigue and recovery in response to high-intensity interval training (HIIT). Methods 22 well-trained male and female team sport athletes (age, 23.0 ± 2.7 years; VO2max, 57.6 ± 8.6 mL·min·kg−1) participated in a six-day running-based HIIT-microcycle with a total of eleven HIIT sessions. Repeated sprint ability (RSA; criterion measure of fatigue and recovery), countermovement jump (CMJ) height, jump efficiency in a multiple rebound jump test (MRJ), 20-m sprint performance, muscle contractile properties, serum concentrations of creatinkinase (CK), c-reactive protein (CRP) and urea as well as perceived mus…

myalgiamedicine.medical_specialtyMultidisciplinarybiologyTeam sportMuscle fatiguebusiness.industryInterval trainingConfidence intervalSprintbiology.proteinPhysical therapymedicineCreatine kinasemedicine.symptombusinessHigh-intensity interval trainingPLOS ONE
researchProduct

Management of Statin Intolerance in 2018: Still More Questions Than Answers.

2018

Statin therapy is generally well tolerated and very effective in the prevention and treatment of cardiovascular disease, regardless of cholesterol levels; however, it can be associated with various adverse events (myalgia, myopathy, rhabdomyolysis, and diabetes mellitus, among others). Patients frequently discontinue statin therapy without medical advice because of perceived side effects and consequently increase their risk for cardiovascular events. In patients with statin intolerance, it may be advisable to change the dose, switch to a different statin, or try an alternate-day regimen. If intolerance is associated with all statins—even at the lowest dose—non-statin drugs and certain nutra…

myalgiamedicine.medical_specialtyStatinDrug-Related Side Effects and Adverse Reactionsmedicine.drug_classDiseaseReview Article030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinePharmacotherapyMedical adviceDiabetes mellitusCardiovascular DiseasemedicineHumansPharmacology (medical)030212 general & internal medicinecardiovascular diseasesAdverse effectIntensive care medicineDietary SupplementHypolipidemic AgentsHypolipidemic Agentbusiness.industrynutritional and metabolic diseasesDisease ManagementGeneral MedicineCholesterol LDLmedicine.diseaseRegimenCardiovascular DiseasesDietary Supplementslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitormedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessDrug-Related Side Effects and Adverse ReactionHumanAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
researchProduct

Opieka koordynowana po zawale serca. Stanowisko Polskiego Towarzystwa Kardiologicznego oraz Agencji Oceny Technologii Medycznych i Taryfikacji

2016

The in-hospital mortality following myocardial infarction has decreased substantially over the last two decades in Poland. However, according to the available evidence approximately every 10th patient discharged after myocardial infarction (MI) dies during next 12 months. We identified the most important barriers (e.g. insufficient risk factors control, insufficient and delayed cardiac rehabilitation, suboptimal pharmacotherapy, delayed complete myocardial revascularisation) and proposed a new nation-wide system of coordinated care after MI. The system should consist of four modules: complete revascularisation, education and rehabilitation programme, electrotherapy (including ICDs and BiVs …

myocardial infarctionpreventionelectrotherapyangioplastycoronary artery diseaserehabilitationKardiologia Polska
researchProduct